On the mechanism of levosimendan-induced dopamine release in the striatum of freely moving rats

Journal of Pharmacological Sciences

Volumn 95, Issue 3, 2004, Pages 299-304

  Rocchitta, Gaia ^a   Delogu, M Rosaria ^a   Migheli, Rossana ^a   Solinas, Luigi ^a   Susini, Giuseppe ^a   Desole, Maria S ^a   Miele, Egidio ^a   Miele, Maddalena ^b   Serra, Pier Andrea ^a  

^a UNIVERSITY OF SASSARI   (Italy)

^b ST MARY S HOSPITAL   (United Kingdom)

Author keywords

Calcium entry; Levosimendan; Microdialysis; Striatal dopamine

Indexed keywords

CALCIUM CHANNEL L TYPE; CALCIUM CHANNEL N TYPE; CALCIUM SENSITIZER; DOPAMINE; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; LEVOSIMENDAN; NIFEDIPINE; OMEGA CONOTOXIN GVIA;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CHELATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORPUS STRIATUM; DIALYSATE LEVEL; DOPAMINE RELEASE; DRUG MECHANISM; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HUMAN; HUMAN CELL; INHIBITION KINETICS; MALE; NONHUMAN; PERFUSION; RAT; SENSITIVITY ANALYSIS; VOLTAGE CLAMP;

EID: 3843052481     PISSN: 13478613     EISSN: None     Source Type: Journal    
DOI: 10.1254/jphs.FPE04003X     Document Type: Article

References (23)

1. Haikala H, Kaivola J, Nissinen E, Wall P, Levijoki, J, Linden IB. Cardiac troponin C as a target protein for a novel calcium sensitizing drug, levosimendan. J Mol Cell Cardiol. 1995;27: 1859-1866.
2. Haikala H, Nissinen E, Etemadzadeh E, Levijoki J, Linden IB. Troponin C-mediated calcium sensitization induced by levosimendan does not impair relaxation. J Cardiovasc Pharmacol. 1995;25:794-801.
3. Hasenfuss G, Pieske B, Castell M, Kretschmann B, Maier LS, Just H. Influence of the novel inotropic agent levosimendan on isometric tension and calcium cycling in failing human myocardium. Circulation. 1998;98:2141-2147.
4. Levijoki J, Pollesello P, Kaivola J, Tilgmann C, Sorsa T, Annila A, et al. Further evidence for the cardiac troponin C mediated calcium sensitization by levosimendan: structure-response and binding analysis with analogs of levosimendan. J Mol Cell Cardiol. 2000;32:479-491.
5. 2+ current via phosphodiesterase-3 inhibition in human cardiac myocytes. Eur J Pharmacol. 2002;435:27-33.
6. Parekh AB, Penner R. Store depletion and calcium influx. Physiol Rev. 1997;77:901-930.
7. 2+ entry activated by S-nitrosylation. J Biol Chem. 1998;273:30855-30858.
8. 2+ entry. J Biol Chem. 1999;274:35318-35324.
9. Rizo J, Südhof TC. SNARES and MUNC18 in synaptic vesicle fusion. Nature Rev Neurosci. 2002;3:641-653.
10. Morton DB, Griffiths PHM. Guidelines on the recognition of pain, distress and discomfort in experimental animals and a hypothesis for assessment. Vet Rec. 1985;116:431-436.
11. Serra PA, Rocchitta G, Delogu MR, Migheli R, Taras MG, Mura MP, et al. Role of the nitric oxide/cyclic GMP pathway and extracellular environment in the nitric oxide donor-induced increase in dopamine secretion from PC12 cells. A microdialysis in vitro study. J Neurochem. 2003;86:1403-1413.
12. Paxinos G, Watson C. Rat brain in stereotaxic coordinates. San Diego: Academic Press; 1986.
13. Serra PA, Rocchitta G, Esposito G, Delogu MR, Migheli R, Miele E, et al. A study on the role of nitric oxide and iron in 3-morpholino-sydnonimine-induced increases in dopamine release in the striatum of freely moving rats. Br J Pharmacol. 2001;134:275-282.
14. Follath F, Cleland JG, Just H, Papp JG, Scholz H, Peuhkurinen K, et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet. 2002;360:196-202.
15. 2+ stores. Cell Calcium. 2001;29:49-58.
16. Bergquist F, Jonason J, Pileblad E, Nissbrandt H. Effects of local administration of L-, N-, and P/Q-type calcium channel blockers on spontaneous dopamine release in the striatum and the substantia nigra: a microdialysis study in rat. J Neurochem. 1998;70:1532-1540.
17. 2+-sensitization. Eur J Pharmacol. 2004;486:1-8.
18. Szilagyi S, Pollesello P, Levijoki J, Kaheinen P, Haikala H, Edes I, et al. The effects of levosimendan and OR-1896 on isolated hearts, myocyte-sized preparations and phosphodiesterase enzymes of the guinea pig. Eur J Pharmacol. 2004;486:67-74.
19. Kato T, Otsu Y, Furune Y, Yamamoto T. Different effects of L-, N- and T-type calcium channel blockers on striatal dopamine releas measured by microdialysis in freely moving rats. Neurochem Int. 1992;21:99-107.
20. v3.1-3.3) antagonists on nigral somatodendritic dopamine release measured by microdialysis. Neuroscience. 2003;120:757-764.
21. 2+ entry activated by S-nitrosylation. J Biol Chem. 1998;273:30855-30858.
22. 2+ entry. J Biol Chem. 1999;274:35318-35324.
23. 2+ entry mediated by store depletion, S-nitrosylation, and TRP3 channels. Comparison of coupling and function. J Biol Chem. 2000; 275:28562-28568.